Significance of membrane type 1 matrix metalloproteinase expression in breast cancer
1Department of Surgery, Tokyo Metropolitan Komagome Hospital.
Abstract:
Expression of matrix metalloproteinases (MMPs) plays an essential role in tumor metastasis and invasion through the degradation of extracellular matrix (ECM). MT1-MMP (membrane type 1 matrix metalloproteinase), a membrane-type MMP, is responsible for the activation of MMP2. In this study the significance of MT1-MMP expression in human breast tumors was investigated by immunocytochemical assay, and its correlation with clinicobiological features was analyzed. MT1-MMP expression was detected in tumor cells and/or stromal cells, and there was a strong correlation between the expressions of MT1-MMP in the two cell types. Out of 183 primary tumors, 103 (56.2%) showed positive staining of MT1-MMP in tumor cells. MT1-MMP expression showed no significant correlation with any of the clinicobiological parameters examined, including hormone receptor status and angiogenesis. In postoperative survival analysis, MT1-MMP expression itself was not a significant prognostic factor. However, in the particular subgroup with the accumulation of thymidine phosphorylase (TP)-positive stromal cells, which have been activated by various stimuli, such as cytokines and hypoxia, MT1-MMP expression had a significant prognostic value. These data suggested that MT1-MMP might function cooperatively with tumor-associated stromal cells for the progression of breast cancer.
Insights
Membrane type 1 matrix metalloproteinase (MT1-MMP) expression in breast tumors is common. While not a direct prognostic factor, MT1-MMP combined with thymidine phosphorylase-positive stromal cells indicates poorer outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Matrix metalloproteinases (MMPs) facilitate tumor metastasis by degrading the extracellular matrix (ECM).
- Membrane type 1 matrix metalloproteinase (MT1-MMP) is crucial for activating MMP2 and is implicated in cancer progression.
Purpose of the Study:
- To investigate the significance of MT1-MMP expression in human breast tumors.
- To analyze the correlation between MT1-MMP expression and clinicobiological features.
- To assess the prognostic value of MT1-MMP in breast cancer survival.
Main Methods:
- Immunocytochemical assay was used to detect MT1-MMP expression in 183 primary breast tumors.
- Correlation analysis was performed between MT1-MMP expression and clinicobiological parameters.
- Postoperative survival analysis was conducted to evaluate prognostic significance.
Main Results:
- MT1-MMP expression was observed in 56.2% of tumor cells and showed strong correlation between tumor and stromal cell expression.
- No significant correlation was found between MT1-MMP expression and clinicobiological parameters like hormone receptor status or angiogenesis.
- MT1-MMP alone was not a significant prognostic factor, but its expression was significant in patients with high thymidine phosphorylase (TP)-positive stromal cells.
Conclusions:
- MT1-MMP expression is prevalent in breast tumors and can be found in both tumor and stromal cells.
- MT1-MMP's prognostic value is context-dependent, becoming significant when co-expressed with TP-positive stromal cells.
- MT1-MMP may cooperate with tumor-associated stromal cells to drive breast cancer progression.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
The Tumor Microenvironment
